REFRACTORY MEDULLOBLASTOMA
Clinical trials for REFRACTORY MEDULLOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MEDULLOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells target deadly childhood brain tumors
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or other rare brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack a protein calle…
Matched conditions: REFRACTORY MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New hope for kids with tough brain tumors: targeted radiation drug enters trial
Disease control Recruiting nowThis study tests a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dose and…
Matched conditions: REFRACTORY MEDULLOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 05:06 UTC